Source:http://linkedlifedata.com/resource/pubmed/id/11562666
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2001-9-19
|
| pubmed:abstractText |
The optimal sentinel lymph node (SLN) biopsy technique remains undefined in breast cancer. Injecting radiotracer or blue dye by a variety of routes seems to stage the axilla with comparable accuracy, and we have hypothesized that the dermal and the parenchymal lymphatics of the breast drain to the same SLN in most patients. Two previous studies from our institution support this concept: (1) a single-surgeon series of 200 consecutive SLN biopsy procedures demonstrating a high dye-isotope concordance for both intradermal (ID) and intraparenchymal (IP) isotope injection, and (2) a series of 100 procedures validated by a backup axillary dissection (ALND) in which the false-negative rate following ID isotope injection was comparable to that of our previous results with IP injection. Here, we directly compare the results of SLN biopsy using either ID or IP isotope injection for our entire experience of SLN biopsy procedures in which a backup ALND was done.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0039-6060
|
| pubmed:author |
pubmed-author:AkhurstTT,
pubmed-author:BorgenP IPI,
pubmed-author:CodyH SHS3rd,
pubmed-author:DerossisA MAM,
pubmed-author:FeyJJ,
pubmed-author:HeerdtA SAS,
pubmed-author:MartinR CRC,
pubmed-author:MontgomeryL LLL,
pubmed-author:PetrekJJ,
pubmed-author:VanZeeK JKJ,
pubmed-author:YehS DSD,
pubmed-author:YeungHH
|
| pubmed:issnType |
Print
|
| pubmed:volume |
130
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
432-8
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11562666-Adult,
pubmed-meshheading:11562666-Aged,
pubmed-meshheading:11562666-Aged, 80 and over,
pubmed-meshheading:11562666-Axilla,
pubmed-meshheading:11562666-Breast,
pubmed-meshheading:11562666-Breast Neoplasms,
pubmed-meshheading:11562666-False Negative Reactions,
pubmed-meshheading:11562666-Female,
pubmed-meshheading:11562666-Humans,
pubmed-meshheading:11562666-Injections,
pubmed-meshheading:11562666-Injections, Intradermal,
pubmed-meshheading:11562666-Lymph Node Excision,
pubmed-meshheading:11562666-Male,
pubmed-meshheading:11562666-Middle Aged,
pubmed-meshheading:11562666-Neoplasm Staging,
pubmed-meshheading:11562666-Radioisotopes,
pubmed-meshheading:11562666-Retrospective Studies,
pubmed-meshheading:11562666-Sentinel Lymph Node Biopsy
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer.
|
| pubmed:affiliation |
Breast Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study
|